Luis Ortega‐Paz

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score

Luis Ortega‐Paz, Davide Capodanno, Tommaso Gori et al. · EuroIntervention · 2017 · 133 citations

Disparate miRNA expression in serum and plasma of patients with acute myocardial infarction: a systematic and paired comparative analysis

Ana Mompeón, Luis Ortega‐Paz, Xavier Vidal‐Gómez et al. · Scientific Reports · 2020 · 90 citations · Full text

10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction

Salvatore Brugaletta, Josep Gómez‐Lara, Luis Ortega‐Paz et al. · Journal of the American College of Cardiology · 2021 · 59 citations · Full text

Percutaneous Coronary Intervention, 10-Year Follow-up, Cardiovascular Disease +9

Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers

Sara Ariotti, Luis Ortega‐Paz, Maarten van Leeuwen et al. · JACC: Cardiovascular Interventions · 2018 · 57 citations

Inflammation, Thrombosis, Hypertension +13

Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial

Rafael Romaguera, Pablo Salinas, Josep Gómez‐Lara et al. · European Heart Journal · 2021 · 43 citations · Full text